Marta S. B.
- Country
- Poland
- Department
- ND
Research Overview
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib in Children and Adolescents with Polyarticular-Course Juvenile Idiopathic Arthritis
- Open-Label, Single-Arm 52‑Week Study of Subcutaneous Anifrolumab 120 mg Weekly in Immunosuppressant‑Naïve and Biologic‑Naïve Systemic Lupus Erythematosus Patients
- Efficacy and Safety Evaluation of Efgartigimod Alfa Subcutaneous Injection in Adult Patients with Primary Sjögren’s Disease: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 22 of 156 partner sites.
Specializations
Inflammatory Arthritis
Marta Szwarc-Bronikowska is involved in clinical research in psoriatic arthritis and polyarticular-course juvenile idiopathic arthritis, with interest in therapies aimed at controlling joint inflammation, improving physical function, and supporting long-term disease management.
- Psoriatic arthritis
- Polyarticular-course juvenile idiopathic arthritis
- Biologic and targeted anti-inflammatory therapy
Her work also extends to treatment strategies addressing persistent disease activity in chronic immune-mediated arthritis.
Autoimmune Systemic Disease
Her research landscape includes primary Sjögren’s disease, reflecting an interest in systemic autoimmune disorders marked by glandular and extra-glandular involvement, fatigue, and ongoing immune dysregulation.
- Primary Sjögren’s disease
- Systemic immune-mediated disease activity
- Autoimmune symptom control
This area connects her clinical focus with therapies designed to reduce broader autoimmune burden and improve patient-relevant outcomes.
Cardiovascular Risk Reduction
She is engaged in studies centered on cardiovascular disease, hypertension, high cardiovascular risk, and established cardiovascular disease, with attention to prevention of major adverse cardiovascular events and management of risk factors.
- Hypertension
- High cardiovascular risk
- Established cardiovascular disease
- Lipoprotein(a)-related risk
Her trial activity also reflects interest in innovative approaches to lowering cardiovascular event burden in at-risk populations.
Metabolic Health
Marta Szwarc-Bronikowska’s clinical trial involvement includes obesity, with emphasis on therapeutic options that support weight reduction and broader metabolic risk improvement in people without diabetes.
- Obesity
- Weight management
- Metabolic risk reduction
This area links her research activity to interventions aimed at improving cardiometabolic health.
Women’s Health and Pain
Her research also includes endometriosis related pain, indicating involvement in therapeutic development for chronic pelvic pain and symptom relief in women’s health.
- Endometriosis related pain
- Chronic pelvic pain
- Symptom-targeted therapy
This domain adds a distinct pain-management dimension to her clinical research portfolio.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.